PTGX
Protagonist Therapeutics, Inc. (PTGX)
Last Price$59.76.8%
Market Cap$3,532.4M
Last Earnings date
Dec'24
Q4 2024
$2.14
54.1% beat
Next quarter EPS Estimate
($0.50)
N/AYoY

PTGX Earnings and Expectations

Revenue

Crunching data... Almost there!

PTGX EPS (Earnings Per Share)

Crunching data... Almost there!

PTGX Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$50.0M$100.0M$150.0M$200.0M$250.0MApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$3,647.0K$13.1M$6,189.0K$10.3M$25.7M$0.0$0.0$0.0$255.0M$4,675.0K
Value Sense
Actual Revenue
Forecast Revenue

PTGX Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$0.0$8,781.0K$11.3M$10.8M$11.7M$6,117.0K$2,353.0K$1,560.0K($8,189.0K)$4,141.0K$2,719.0K$3,647.0K$6,217.0K$13.1M$5,650.0K$6,189.0K$2,265.0K$10.3M$8,617.0K$25.7M$859.0K$0.0$0.0$0.0$0.0$0.0$60.0M$255.0M$4,167.0K$4,675.0K$170.6M
Revenue estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$8,684.7K$8,684.7K$8,684.7K$8,684.7K$4,894.6K$11.2M$4,826.5K$4,227.8K$1,480.0K$2,950.0K$2,866.7K$2,700.0K$1,500.0K$5,171.4K$1,742.9K$5,071.4K$21.2M$460.0K$460.0K$3,333.3K$2,000.0K$2,000.0K$2,000.0K$60.0M$262.5M$3,141.8K$3,112.5K$132.4M
Revenue surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%24.1%34.4%29.6%72.9%68.1%173.1%14.2%35.7%146.4%110.7%357.5%109.3%312.6%56.2%490.2%69.9%21.4%86.7%100.0%100.0%100.0%100.0%100.0%0.0%2.9%32.6%50.2%28.9%
EPS actual($0.46)($0.55)($0.59)($0.93)($2.00)($0.43)($0.84)($0.67)($0.84)($0.89)($0.29)($0.15)($0.36)($0.41)($0.38)($0.57)($0.58)($1.18)($0.61)($0.63)($0.72)($0.59)($0.21)($0.48)($0.54)($0.69)($0.70)($0.77)($0.43)($0.83)($0.62)($0.64)($0.62)($0.68)($0.58)$0.45$3.41($0.50)($0.54)$2.14
EPS estimateN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A($0.22)($0.22)($0.22)($0.22)($0.59)($0.28)($0.71)($0.65)($0.69)($0.57)($0.61)($0.48)($0.57)($0.55)($0.67)($0.78)($0.54)($0.94)($0.94)($0.67)($0.73)($0.73)($0.73)$0.05$3.37($0.60)($0.58)$1.39
EPS surprise0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%63.6%86.4%72.7%159.1%1.0%321.4%13.7%2.8%4.0%4.4%65.7%0.4%4.9%26.5%4.5%1.5%20.4%11.3%33.7%4.2%14.6%6.4%20.1%739.3%1.3%16.0%6.5%54.1%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$170.6M 184.4% YoY
$170.6M 188.4% YoY
100.0% margin
Operating income
$126.8M 450.0% YoY
74.3% margin
Other: $31.0K
Net interest: $6,853.0K
Operating expenses
$43.9M 18.7% YoY
Pre-tax income
$133.7M 389.0% YoY
78.3% margin
Net income
$131.7M 381.7% YoY
77.2% margin
Income tax
$1,990.0K
1.5% tax rate
R&D
$34.9M 20.8% YoY
20.5% of revenue
SG&A
$8,954.0K 11.2% YoY
5.2% of revenue

Competing with PTGX Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!

FAQ

1. When was Protagonist Therapeutics, Inc.'s last earnings date?

Protagonist Therapeutics, Inc.'s last earnings date was Dec'24 (Q4 2024).

2. What is Protagonist Therapeutics, Inc.'s EPS, and was there a surprise?

4. What is Protagonist Therapeutics, Inc.'s next quarter EPS estimate?

Protagonist Therapeutics, Inc.'s next quarter EPS estimate is ($0.50), with an expected N/A YoY growth.